Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Évaluation clinique d'une technologie de diagnostic du sommeil pédiatrique

13 novembre 2026 mis à jour par: Acurable Ltd.

The objective of this project is to gather research data and subsequently evaluate algorithms to demonstrate clinical efficacy of a novel sleep apnoea detection system in the paediatric population.

The Study will involve patients who will have been referred for diagnosis of sleep apnoea, and the ultimate aim will be to compare the output of a novel apnoea detection system against in -clinic polysomnography or cardio-respiratory polygraphy, assess acceptance of the novel system in the home environment, assess validity in patients on ventilation, and on a cohort with BMI SDS of 3 or more.

Aperçu de l'étude

Statut

Recrutement

Les conditions

Description détaillée

The objective of this project is to gather research data and subsequently evaluate algorithms to demonstrate clinical efficacy of a novel sleep apnoea detection system in the paediatric population.

The Study will involve patients who will have been referred for diagnosis of sleep apnoea, and the ultimate aim will be to compare the output of a novel apnoea detection system against in -clinic polysomnography or cardio-respiratory polygraphy, assess acceptance of the novel system in the home environment, assess validity in patients on ventilation, and on a cohort with BMI SDS of 3 or more.

Patients who are referred to the clinic for the first and second group will spend one night's sleep in the clinic for group 1 and group 2. They will wear a polysomnography or cardio-respiratory polygraphy system (current goldstandard) and the novel device. At the end of the trial, we will compare the diagnosis results from both systems.

Patients who are referred for home diagnosis of sleep apnoea or overnight oximetry at home (group 3) will wear the standard clinical sleep test system and the novel device. At the end of the trial, the acceptability of the novel device will be assessed.

Patients who are on mechanical ventilation and referred for diagnosis of sleep apnoea in hospital or at home will wear the standard clinical sleep test system and the novel device. At the end of the trial, the validity of the diagnosis from the novel device will be assessed.

Patients who are referred for either at home or in hospital diagnosis of sleep apnoea with a BMI SDS score of 3 or more will wear the standard clinical sleep test system and the novel device. At the end of the trial, we will compare the diagnosis results from both systems.

Type d'étude

Observationnel

Inscription (Estimé)

345

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Lieux d'étude

      • Sheffield, Royaume-Uni, S10 2TH
        • Recrutement
        • Sheffield Children Hospital
        • Contact:
        • Chercheur principal:
          • Heather Elphick
      • Southampton, Royaume-Uni
        • Recrutement
        • Southampton Children's Hospital
        • Contact:
          • Orsina Dessi
        • Chercheur principal:
          • Hazel Evans

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

1 an à 18 ans (Enfant, Adulte)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

Méthode d'échantillonnage

Échantillon de probabilité

Population étudiée

all children who have been referred for a sleep test.

La description

Inclusion Criteria:

  • Children older than one year old (older than eight years old for studies at-home) and below 18 years of age.
  • Children who have been referred to a sleep clinic due to suspicion of sleep apnoea.

Exclusion Criteria:

  • Patients whose parents/legal guardians/carers are not fluent in English, or who have special communication needs.
  • Known allergy to the adhesive dressing.
  • Patients with physical or mental impairments who would be too distressed with additional sensors on themselves.
  • Patients with not enough space on the neck area to fit the sensor.
  • Clinical problem in the area in which the device will be attached, eg skin condition ●. For patients conducting the study at home, patients with neurocognitive impairments which may increase the risk of them putting the sensor in their mouth, who do not have overnight carers

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Modèles d'observation: COHORT
  • Perspectives temporelles: PROSPECTIVE

Cohortes et interventions

Groupe / Cohorte
Intervention / Traitement
test group

Test group will wear PSG

The patient will wear the novel wearable paediatric device at the same time as polysmnography

Novel wearable device

THis group will wear the novel device

The patient will wear the novel wearable paediatric device at the same time as polysmnography

Home

40 consecutive patients (plus/minus 30% to account for potential dropouts, invalid signals from the gold-standard), who will have been referred for at home diagnosis of sleep apnoea or overnight oximetry at home. Each site will recruit, in parallel, consecutive patients from the moment the first patient in this group is recruited at that site. Each subject whose parents are willing to take part in the trial and meets the inclusion criteria will be included in the study. Criteria for inclusion are children older than 8 years old and referral for overnight assessment for evaluation of possible sleep apnoea. Additionally, patients will be excluded from the study if the clinical team consider the child is too unwell or distressed to be approached or one of the exclusion criteria below. This patient cohort will be used to assess the acceptance of the AcuPebble technology in the home environment.

The patient will wear the novel wearable paediatric device at the same time as polysmnography

Ventilation

30 patients will be recruited (plus/minus 30% to account for potential dropouts, invalid signals from the gold-standard), who are on mechanical ventilation and have been referred for diagnosis of sleep apnoea. Each subject whose parents are willing to take part in the trial and meets the inclusion criteria will be included in the study. Criteria for inclusion are children older than 1 year old, referral for overnight assessment for evaluation or monitoring of sleep apnoea, and being on mechanical ventilation while conducting the study in hospital, or over 8 years old, referral for overnight assessment for evaluation or monitoring of sleep apnoea, and being on mechanical ventilation while conducting the study at home. Patients will be excluded from the study if the clinical team consider the child is too unwell or distressed to be approached or one of the exclusion criteria below. These patients will be included in a final analysis of diagnostic validity.

The patient will wear the novel wearable paediatric device at the same time as polysmnography

High BMI

75 patients will be recruited (plus/minus 30% to account for potential dropouts, or invalid signals from the gold-standard), who have a BMI SDS score of 3 or more and have been referred for either at-home or in-hospital diagnosis of sleep apnoea. Each subject whose parents are willing to take part in the trial and meets the inclusion criteria will be included in the study. If their study is to take place in the home, only children who are older than 8 will be included. If their study is to take place in hospital, children over the age of 1 will be included. Patients will be excluded from the study if the clinical team consider the child is too unwell or distressed to be approached or one of the exclusion criteria below. These patients will be included in a final analysis of sensitivity and specificity for this cohort.

The patient will wear the novel wearable paediatric device at the same time as polysmnography

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Specificity and sensitivity of novel device
Délai: 6 months

specificity and sensitivity of the output of the novel wearable device against polysomnography

6 months

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Les enquêteurs

  • Directeur d'études: Ruth Kingshott, PhD, Sheffield Children's NHS Foundation Trust

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

19 février 2020

Achèvement primaire (Estimé)

14 octobre 2027

Achèvement de l'étude (Estimé)

14 octobre 2027

Dates d'inscription aux études

Première soumission

23 juillet 2019

Première soumission répondant aux critères de contrôle qualité

23 juillet 2019

Première publication (Réel)

25 juillet 2019

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

18 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

13 novembre 2026

Dernière vérification

1 novembre 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner